The Cannabis Comeback? 3 Marijuana Stocks to Watch Now
The cannabis industry is entering September, and investors are once again searching for opportunities across the sector. After years of volatility, several marijuana companies are showing signs of stronger financial performance. Revenue is improving for some operators. Meanwhile, others are cutting costs, strengthening margins, and expanding internationally. That combination could put marijuana stocks back on investors’ radar. However, this is no longer simply a story about rapid expansion. Investors are becoming more selective about which cannabis companies deserve their attention. Today, profitability matters. Cash flow matters. Additionally, investors want companies with strong brands and opportunities beyond their existing markets. International cannabis growth has become particularly important. Europe continues expanding its medical cannabis industry. As a result, Canadian producers are positioning themselves to capture growing international demand. Meanwhile, the United States remains an important potential catalyst. Changes to federal cannabis regulations could eventually reshape the industry’s investment landscape.
Canadian Producers Positioned for Growth
Still, investors should not depend entirely on regulatory changes to drive marijuana stocks higher. Instead, companies must demonstrate improving businesses and stronger financial results. Fortunately, several cannabis companies are beginning to deliver encouraging numbers. Tilray Brands recently completed a record fiscal year for revenue. Meanwhile, Canopy Growth reported double-digit revenue growth during its latest quarter. Village Farms International also delivered record cannabis revenue and international export sales. These improvements could make the sector increasingly interesting during September. Of course, marijuana stocks remain highly speculative investments. Sharp price movements can happen quickly following financial, regulatory, or political developments. Therefore, investors should carefully research each company before making investment decisions. Three cannabis stocks currently stand out as we enter September 2026. Tilray Brands (NASDAQ: TLRY), Canopy Growth (NASDAQ: CGC), and Village Farms International (NASDAQ: VFF) each offer different opportunities. More importantly, improving fundamentals could make these three marijuana stocks worth watching closely.
[Read More] 3 Marijuana Stocks To Focus On For Future Growth And Profits
3 Top Marijuana Stocks to Watch in September 2026
- Tilray Brands (NASDAQ: TLRY)
- Canopy Growth Corporation (NASDAQ: CGC)
- Village Farms International (NASDAQ: VFF)
Tilray Brands (NASDAQ: TLRY)
Tilray Brands remains one of the most recognizable cannabis companies trading on a major U.S. exchange. However, the company has evolved considerably beyond its original marijuana business. Today, Tilray operates across cannabis, beverages, wellness, distribution, and hospitality. Cannabis still remains an important part of the company’s long-term strategy. Tilray owns several established cannabis brands, including Good Supply, Redecan, Broken Coast, and RIFF. Additionally, the company has developed a sizable international medical cannabis operation. Europe remains especially important to Tilray’s expansion strategy. The company has production capabilities that help serve growing international medical cannabis markets. Meanwhile, Tilray’s largest physical presence in the United States comes through its beverage and consumer businesses. Those operations include SweetWater Brewing and several additional beverage brands. However, Tilray currently operates zero marijuana dispensaries in the United States. Therefore, TLRY offers investors a different approach compared with traditional American multi-state cannabis operators.
Financially, fiscal 2026 represented an important growth year for Tilray. The company reported record annual net revenue of approximately $915.5 million. That represented an 11% increase from $821.3 million during the previous year. Cannabis net revenue also increased 8% to approximately $268.3 million. Cannabis gross profit also increased 8% to approximately $107.1 million. Meanwhile, cannabis’s gross margin remained approximately 40%. Tilray’s beverage business generated approximately $254 million in annual net revenue. Distribution revenue performed even better, reaching approximately $327.2 million. Overall gross profit increased 8% to approximately $260.4 million. Additionally, adjusted net income increased almost 90% to approximately $12.2 million. Adjusted EBITDA reached approximately $61.1 million, compared with $55 million previously. Nevertheless, Tilray reported a GAAP net loss of approximately $105.2 million. Therefore, investors should continue monitoring profitability. Still, rising revenue makes TLRY an interesting marijuana stock entering September.
[Read More] The Best Way Marijuana Stock Investing Can Work For You
Canopy Growth Corporation (NASDAQ: CGC)
Canopy Growth remains another well-known Canadian cannabis company among marijuana stock investors. The company sells medical and recreational cannabis products through several established brands. Those brands include Tweed, 7ACRES, DOJA, and other recognizable cannabis names. Canada remains the company’s primary cannabis market. However, management continues pursuing growth opportunities internationally. Canopy has also maintained exposure to the potential long-term development of the American cannabis industry. Its U.S. strategy has historically involved Canopy USA and several recognizable cannabis businesses. However, investors should distinguish Canopy Growth’s operations from separately structured American cannabis interests.
Meanwhile, Canopy’s international cannabis operations could become increasingly important. Europe provides another opportunity as medical marijuana markets continue developing. Additionally, Canopy Growth has strengthened its Canadian cannabis portfolio through acquisitions. The company does not directly operate a traditional nationwide U.S. marijuana dispensary network. Therefore, its current investment story depends heavily on improving Canadian operations, expanding internationally, and delivering stronger financial performance.
Canopy Growth’s latest financial results provided several encouraging signs entering September. First-quarter fiscal 2027 net revenue reached approximately C$81.2 million. That represented 13% year-over-year growth. Cannabis net revenue increased 14% to approximately C$65.1 million. Moreover, Canadian adult-use cannabis revenue increased 10% to C$29.7 million. Canadian medical cannabis performed even better during the quarter. Medical cannabis revenue increased 22% to approximately C$25.8 million. Additionally, international cannabis revenue increased 10% to C$9.6 million. Strength in Europe, particularly Poland, helped support international growth. Meanwhile, adjusted gross margin improved to 31%, compared with 25% previously. Most importantly, Canopy continued reducing its losses. The company’s net loss narrowed to approximately C$14.6 million during the quarter. That represented a 68% year-over-year reduction. Therefore, Canopy appears to be moving toward stronger financial performance. Consequently, CGC remains a marijuana stock worth monitoring closely throughout September 2026.
[Read More] 3 Marijuana Stocks To Watch At The End Of The Week
Village Farms International (NASDAQ: VFF)
Village Farms International offers investors a different approach to the cannabis industry. The company developed its expertise through decades of controlled-environment agriculture and large-scale greenhouse production. Today, cannabis has become the company’s primary growth engine. Village Farms owns Pure Sunfarms, one of Canada’s leading cannabis producers. Pure Sunfarms operates large greenhouse facilities in British Columbia. Additionally, Village Farms owns a controlling interest in Quebec-based cannabis company Rose LifeScience.
The company has also expanded aggressively into international medical cannabis markets. Europe has become particularly important to its long-term growth strategy. Meanwhile, Village Farms continues developing its cannabis operations in the Netherlands. These international businesses could provide additional growth opportunities over the coming years. In the United States, Village Farms has exposure through its hemp-derived cannabinoid business. However, the company currently operates zero marijuana dispensaries in the United States. Therefore, VFF’s cannabis growth story currently centers heavily around Canada, Europe, and international exports.
Financially, Village Farms delivered impressive second-quarter 2026 results entering September. Consolidated net sales reached approximately $64 million. That represented 7% year-over-year growth and 27% sequential growth. More importantly, cannabis net sales reached a record $53.5 million. Cannabis gross margin also improved significantly to 51%. The comparable margin during the previous year was approximately 42%. Additionally, cannabis net income increased 21% to approximately $8.6 million. Adjusted cannabis EBITDA reached a record $15.3 million. That represented approximately 29% of cannabis sales. International exports were another major bright spot. Export sales reached a record $20.9 million. That represented 74% year-over-year growth and 43% sequential growth. Furthermore, consolidated net income reached approximately $7.1 million, or $0.06 per share. Operating cash flow totaled approximately $8.9 million. Village Farms also ended the quarter with approximately $73 million in cash. Therefore, VFF could be one of the more interesting marijuana stocks to watch during September 2026.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
